Clinical Trials Browser

Not yet recruiting × INDUSTRY × Lymphoma, Non-Hodgkin × Clear all

NCT07454863 2026-03-06

A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15)

Phase 1 Not yet recruiting

Lymphoma, Non-Hodgkin

NCT07101328 2026-03-04

BAF_FRontier-1

Phase 1 Not yet recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT07003178 2025-06-04

A Study to Evaluate the Safety and Clinical Efficacy of STR-P004

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, Non-Hodgkin

NCT06845241 2025-02-25

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Phase 1/2 Not yet recruiting

Lymphoma, Non-Hodgkin, Recurrence

NCT06318884 2024-03-22

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma

Phase 1 Not yet recruiting

Lymphoma, Non-Hodgkin

NCT05381181 2023-01-27

Safety and Efficacy Evaluation of Next-generation CD19-UCART

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma